Click for best price
Hepatitis C Virus HCV Market Size, Share 2023
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
This report aims to provide a comprehensive presentation of the global market for Hepatitis C Virus (HCV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis C Virus (HCV). This report contains market size and forecasts of Hepatitis C Virus (HCV) in global, including the following market information:
Global Hepatitis C Virus (HCV) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Hepatitis C Virus (HCV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
We surveyed the Hepatitis C Virus (HCV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis C Virus (HCV) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, by Type, 2022 (%)
Hepatitis C Drugs
Hepatitis C Test Kit
Global Hepatitis C Virus (HCV) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Hepatitis C Virus (HCV) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis C Virus (HCV) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hepatitis C Virus (HCV) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis C Virus (HCV), market overview.
Chapter 2: Global Hepatitis C Virus (HCV) market size in revenue.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis C Virus (HCV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hepatitis C Virus (HCV) Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis C Virus (HCV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis C Virus (HCV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis C Virus (HCV) Overall Market Size
2.1 Global Hepatitis C Virus (HCV) Market Size: 2022 VS 2030
2.2 Global Hepatitis C Virus (HCV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis C Virus (HCV) Players in Global Market
3.2 Top Global Hepatitis C Virus (HCV) Companies Ranked by Revenue
3.3 Global Hepatitis C Virus (HCV) Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis C Virus (HCV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hepatitis C Virus (HCV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis C Virus (HCV) Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis C Virus (HCV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis C Virus (HCV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis C Virus (HCV) Market Size Markets, 2022 & 2030
4.1.2 Hepatitis C Drugs
4.1.3 Hepatitis C Test Kit
4.2 By Type - Global Hepatitis C Virus (HCV) Revenue & Forecasts
4.2.1 By Type - Global Hepatitis C Virus (HCV) Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis C Virus (HCV) Revenue, 2024-2030
4.2.3 By Type - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis C Virus (HCV) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.2 By Application - Global Hepatitis C Virus (HCV) Revenue & Forecasts
5.2.1 By Application - Global Hepatitis C Virus (HCV) Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis C Virus (HCV) Revenue, 2024-2030
5.2.3 By Application - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Hepatitis C Virus (HCV) Market Size, 2022 & 2030
6.2 By Region - Global Hepatitis C Virus (HCV) Revenue & Forecasts
6.2.1 By Region - Global Hepatitis C Virus (HCV) Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis C Virus (HCV) Revenue, 2024-2030
6.2.3 By Region - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Hepatitis C Virus (HCV) Revenue, 2018-2030
6.3.2 US Hepatitis C Virus (HCV) Market Size, 2018-2030
6.3.3 Canada Hepatitis C Virus (HCV) Market Size, 2018-2030
6.3.4 Mexico Hepatitis C Virus (HCV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Hepatitis C Virus (HCV) Revenue, 2018-2030
6.4.2 Germany Hepatitis C Virus (HCV) Market Size, 2018-2030
6.4.3 France Hepatitis C Virus (HCV) Market Size, 2018-2030
6.4.4 U.K. Hepatitis C Virus (HCV) Market Size, 2018-2030
6.4.5 Italy Hepatitis C Virus (HCV) Market Size, 2018-2030
6.4.6 Russia Hepatitis C Virus (HCV) Market Size, 2018-2030
6.4.7 Nordic Countries Hepatitis C Virus (HCV) Market Size, 2018-2030
6.4.8 Benelux Hepatitis C Virus (HCV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Hepatitis C Virus (HCV) Revenue, 2018-2030
6.5.2 China Hepatitis C Virus (HCV) Market Size, 2018-2030
6.5.3 Japan Hepatitis C Virus (HCV) Market Size, 2018-2030
6.5.4 South Korea Hepatitis C Virus (HCV) Market Size, 2018-2030
6.5.5 Southeast Asia Hepatitis C Virus (HCV) Market Size, 2018-2030
6.5.6 India Hepatitis C Virus (HCV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Hepatitis C Virus (HCV) Revenue, 2018-2030
6.6.2 Brazil Hepatitis C Virus (HCV) Market Size, 2018-2030
6.6.3 Argentina Hepatitis C Virus (HCV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis C Virus (HCV) Revenue, 2018-2030
6.7.2 Turkey Hepatitis C Virus (HCV) Market Size, 2018-2030
6.7.3 Israel Hepatitis C Virus (HCV) Market Size, 2018-2030
6.7.4 Saudi Arabia Hepatitis C Virus (HCV) Market Size, 2018-2030
6.7.5 UAE Hepatitis C Virus (HCV) Market Size, 2018-2030
7 Hepatitis C Virus (HCV) Companies Profiles
7.1 Gilead
7.1.1 Gilead Company Summary
7.1.2 Gilead Business Overview
7.1.3 Gilead Hepatitis C Virus (HCV) Major Product Offerings
7.1.4 Gilead Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.1.5 Gilead Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis C Virus (HCV) Major Product Offerings
7.2.4 Merck Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Hepatitis C Virus (HCV) Major Product Offerings
7.3.4 AbbVie Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 J&J
7.4.1 J&J Company Summary
7.4.2 J&J Business Overview
7.4.3 J&J Hepatitis C Virus (HCV) Major Product Offerings
7.4.4 J&J Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.4.5 J&J Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Hepatitis C Virus (HCV) Major Product Offerings
7.5.4 Bristol-Myers Squibb Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 Kawin
7.6.1 Kawin Company Summary
7.6.2 Kawin Business Overview
7.6.3 Kawin Hepatitis C Virus (HCV) Major Product Offerings
7.6.4 Kawin Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.6.5 Kawin Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Hepatitis C Virus (HCV) Major Product Offerings
7.7.4 Abbott Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.7.5 Abbott Key News & Latest Developments
7.8 Siemens Healthineers
7.8.1 Siemens Healthineers Company Summary
7.8.2 Siemens Healthineers Business Overview
7.8.3 Siemens Healthineers Hepatitis C Virus (HCV) Major Product Offerings
7.8.4 Siemens Healthineers Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.8.5 Siemens Healthineers Key News & Latest Developments
7.9 Roche Diagnostics
7.9.1 Roche Diagnostics Company Summary
7.9.2 Roche Diagnostics Business Overview
7.9.3 Roche Diagnostics Hepatitis C Virus (HCV) Major Product Offerings
7.9.4 Roche Diagnostics Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.9.5 Roche Diagnostics Key News & Latest Developments
7.10 altona Diagnostics
7.10.1 altona Diagnostics Company Summary
7.10.2 altona Diagnostics Business Overview
7.10.3 altona Diagnostics Hepatitis C Virus (HCV) Major Product Offerings
7.10.4 altona Diagnostics Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.10.5 altona Diagnostics Key News & Latest Developments
7.11 GeneProof
7.11.1 GeneProof Company Summary
7.11.2 GeneProof Business Overview
7.11.3 GeneProof Hepatitis C Virus (HCV) Major Product Offerings
7.11.4 GeneProof Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.11.5 GeneProof Key News & Latest Developments
7.12 Sansure Biotech
7.12.1 Sansure Biotech Company Summary
7.12.2 Sansure Biotech Business Overview
7.12.3 Sansure Biotech Hepatitis C Virus (HCV) Major Product Offerings
7.12.4 Sansure Biotech Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.12.5 Sansure Biotech Key News & Latest Developments
7.13 Daan Gene
7.13.1 Daan Gene Company Summary
7.13.2 Daan Gene Business Overview
7.13.3 Daan Gene Hepatitis C Virus (HCV) Major Product Offerings
7.13.4 Daan Gene Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.13.5 Daan Gene Key News & Latest Developments
7.14 BGI Group
7.14.1 BGI Group Company Summary
7.14.2 BGI Group Business Overview
7.14.3 BGI Group Hepatitis C Virus (HCV) Major Product Offerings
7.14.4 BGI Group Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.14.5 BGI Group Key News & Latest Developments
7.15 Abiores
7.15.1 Abiores Company Summary
7.15.2 Abiores Business Overview
7.15.3 Abiores Hepatitis C Virus (HCV) Major Product Offerings
7.15.4 Abiores Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.15.5 Abiores Key News & Latest Developments
7.16 ACON Biotech
7.16.1 ACON Biotech Company Summary
7.16.2 ACON Biotech Business Overview
7.16.3 ACON Biotech Hepatitis C Virus (HCV) Major Product Offerings
7.16.4 ACON Biotech Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.16.5 ACON Biotech Key News & Latest Developments
7.17 Nectar Lifesciences
7.17.1 Nectar Lifesciences Company Summary
7.17.2 Nectar Lifesciences Business Overview
7.17.3 Nectar Lifesciences Hepatitis C Virus (HCV) Major Product Offerings
7.17.4 Nectar Lifesciences Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.17.5 Nectar Lifesciences Key News & Latest Developments
7.18 Everlywell
7.18.1 Everlywell Company Summary
7.18.2 Everlywell Business Overview
7.18.3 Everlywell Hepatitis C Virus (HCV) Major Product Offerings
7.18.4 Everlywell Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.18.5 Everlywell Key News & Latest Developments
7.19 bioLytical
7.19.1 bioLytical Company Summary
7.19.2 bioLytical Business Overview
7.19.3 bioLytical Hepatitis C Virus (HCV) Major Product Offerings
7.19.4 bioLytical Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.19.5 bioLytical Key News & Latest Developments
7.20 Liferiver
7.20.1 Liferiver Company Summary
7.20.2 Liferiver Business Overview
7.20.3 Liferiver Hepatitis C Virus (HCV) Major Product Offerings
7.20.4 Liferiver Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.20.5 Liferiver Key News & Latest Developments
7.21 3B BlackBio Biotech India Limited
7.21.1 3B BlackBio Biotech India Limited Company Summary
7.21.2 3B BlackBio Biotech India Limited Business Overview
7.21.3 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Major Product Offerings
7.21.4 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Revenue in Global Market (2018-2023)
7.21.5 3B BlackBio Biotech India Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis C Virus (HCV) Market Opportunities & Trends in Global Market
Table 2. Hepatitis C Virus (HCV) Market Drivers in Global Market
Table 3. Hepatitis C Virus (HCV) Market Restraints in Global Market
Table 4. Key Players of Hepatitis C Virus (HCV) in Global Market
Table 5. Top Hepatitis C Virus (HCV) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hepatitis C Virus (HCV) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hepatitis C Virus (HCV) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hepatitis C Virus (HCV) Product Type
Table 9. List of Global Tier 1 Hepatitis C Virus (HCV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis C Virus (HCV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Hepatitis C Virus (HCV) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hepatitis C Virus (HCV) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Hepatitis C Virus (HCV) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hepatitis C Virus (HCV) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Hepatitis C Virus (HCV) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hepatitis C Virus (HCV) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2024-2030
Table 30. Gilead Company Summary
Table 31. Gilead Hepatitis C Virus (HCV) Product Offerings
Table 32. Gilead Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Hepatitis C Virus (HCV) Product Offerings
Table 36. Merck Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. AbbVie Company Summary
Table 39. AbbVie Hepatitis C Virus (HCV) Product Offerings
Table 40. AbbVie Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 41. AbbVie Key News & Latest Developments
Table 42. J&J Company Summary
Table 43. J&J Hepatitis C Virus (HCV) Product Offerings
Table 44. J&J Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 45. J&J Key News & Latest Developments
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Hepatitis C Virus (HCV) Product Offerings
Table 48. Bristol-Myers Squibb Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. Kawin Company Summary
Table 51. Kawin Hepatitis C Virus (HCV) Product Offerings
Table 52. Kawin Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 53. Kawin Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott Hepatitis C Virus (HCV) Product Offerings
Table 56. Abbott Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 57. Abbott Key News & Latest Developments
Table 58. Siemens Healthineers Company Summary
Table 59. Siemens Healthineers Hepatitis C Virus (HCV) Product Offerings
Table 60. Siemens Healthineers Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 61. Siemens Healthineers Key News & Latest Developments
Table 62. Roche Diagnostics Company Summary
Table 63. Roche Diagnostics Hepatitis C Virus (HCV) Product Offerings
Table 64. Roche Diagnostics Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 65. Roche Diagnostics Key News & Latest Developments
Table 66. altona Diagnostics Company Summary
Table 67. altona Diagnostics Hepatitis C Virus (HCV) Product Offerings
Table 68. altona Diagnostics Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 69. altona Diagnostics Key News & Latest Developments
Table 70. GeneProof Company Summary
Table 71. GeneProof Hepatitis C Virus (HCV) Product Offerings
Table 72. GeneProof Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 73. GeneProof Key News & Latest Developments
Table 74. Sansure Biotech Company Summary
Table 75. Sansure Biotech Hepatitis C Virus (HCV) Product Offerings
Table 76. Sansure Biotech Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 77. Sansure Biotech Key News & Latest Developments
Table 78. Daan Gene Company Summary
Table 79. Daan Gene Hepatitis C Virus (HCV) Product Offerings
Table 80. Daan Gene Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 81. Daan Gene Key News & Latest Developments
Table 82. BGI Group Company Summary
Table 83. BGI Group Hepatitis C Virus (HCV) Product Offerings
Table 84. BGI Group Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 85. BGI Group Key News & Latest Developments
Table 86. Abiores Company Summary
Table 87. Abiores Hepatitis C Virus (HCV) Product Offerings
Table 88. Abiores Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 89. Abiores Key News & Latest Developments
Table 90. ACON Biotech Company Summary
Table 91. ACON Biotech Hepatitis C Virus (HCV) Product Offerings
Table 92. ACON Biotech Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 93. ACON Biotech Key News & Latest Developments
Table 94. Nectar Lifesciences Company Summary
Table 95. Nectar Lifesciences Hepatitis C Virus (HCV) Product Offerings
Table 96. Nectar Lifesciences Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 97. Nectar Lifesciences Key News & Latest Developments
Table 98. Everlywell Company Summary
Table 99. Everlywell Hepatitis C Virus (HCV) Product Offerings
Table 100. Everlywell Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 101. Everlywell Key News & Latest Developments
Table 102. bioLytical Company Summary
Table 103. bioLytical Hepatitis C Virus (HCV) Product Offerings
Table 104. bioLytical Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 105. bioLytical Key News & Latest Developments
Table 106. Liferiver Company Summary
Table 107. Liferiver Hepatitis C Virus (HCV) Product Offerings
Table 108. Liferiver Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 109. Liferiver Key News & Latest Developments
Table 110. 3B BlackBio Biotech India Limited Company Summary
Table 111. 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Product Offerings
Table 112. 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Revenue (US$, Mn) & (2018-2023)
Table 113. 3B BlackBio Biotech India Limited Key News & Latest Developments
List of Figures
Figure 1. Hepatitis C Virus (HCV) Segment by Type in 2022
Figure 2. Hepatitis C Virus (HCV) Segment by Application in 2022
Figure 3. Global Hepatitis C Virus (HCV) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis C Virus (HCV) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hepatitis C Virus (HCV) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis C Virus (HCV) Revenue in 2022
Figure 8. By Type - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 16. US Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 20. Germany Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 21. France Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 28. China Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 32. India Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 34. Brazil Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Hepatitis C Virus (HCV) Revenue Market Share, 2018-2030
Figure 37. Turkey Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Hepatitis C Virus (HCV) Revenue, (US$, Mn), 2018-2030
Figure 41. Gilead Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AbbVie Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. J&J Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Kawin Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Abbott Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Siemens Healthineers Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Roche Diagnostics Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. altona Diagnostics Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GeneProof Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sansure Biotech Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Daan Gene Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. BGI Group Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Abiores Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. ACON Biotech Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Nectar Lifesciences Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Everlywell Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. bioLytical Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Liferiver Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
